Dr. Scott M. Schuetze, MD, PhD
- Medicare services, 2024
- 209
- Medicare patients, 2024
- 80
- Part D claims, 2024
- 358
- Publications
- 67
- Clinical trials
- 11
- Practice address
- 1500 E Medical Center Dr, Ann Arbor, MI 48109
- Practice phone
- Call (734) 936-4000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
University Hospital
School-Based Health Center · Ann Arbor, Michigan
Find Dr. Schuetze's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Scott M. Schuetze is a medical oncologist in Ann Arbor, Michigan
Dr. Schuetze practices at University Hospital in Ann Arbor, Michigan.
Dr. Schuetze's NPI, 1548346414, was assigned on October 31, 2006. Dr. Schuetze graduated from Oregon Health Sciences University School of Medicine in 1993. Dr. Schuetze holds Michigan license 4301084113.
- NPI
- 1548346414NPI Registry (opens in a new tab)
- Medicare PAC ID
- 5092775932
- NPI enumeration date
- October 31, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (734) 936-4000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 59
- Medical school graduation
- 1993
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Scott M. Schuetze practices at University Hospital in Ann Arbor, Michigan
Dr. Schuetze's primary practice is University Hospital, at 1500 E Medical Center Dr, Ann Arbor, MI 48109. The practice phone is (734) 936-4000.
- University Hospital1500 E Medical Center Dr, Ann Arbor, MI 48109Phone(734) 936-4000
Source: Dmand AI Affiliation Data
Dr. Scott M. Schuetze is affiliated with 2 sites of care and 1 medical group
Dr. Schuetze's primary practice is University Hospital in Ann Arbor, Michigan. Dr. Schuetze is also affiliated with University Hospital. The medical group on file is University of Michigan Health. Dr. Schuetze's employer is on file too: a school & student health.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Scott M. Schuetze's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schuetze practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| University Hospital | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Scott M. Schuetze is one of 171 medical oncologists in Michigan
Medical oncology is Dr. Schuetze's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Schuetze is licensed in Michigan.
Specialties and state licenses
- Medical oncology, MichiganPrimary
Medical oncologists near Dr. Schuetze
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Scott M. Schuetze billed Medicare for 209 services in 2024
CMS data shows 209 Medicare services from Dr. Schuetze across 5 procedure codes in 2024, for 80 Medicare patients. Medicare paid $14,887 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Schuetze's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 1622024: 1705%
- Other services
- 2023: 02024: 39
Dr. Schuetze compared with the Michigan median for medical oncologists, 2024
- Dr. Schuetze
- Michigan median
- Medicare services
- 209vs 36443% below
- Medicare patients
- 80vs 13641% below
- Part D claims
- 223vs 33433% below
Medians across 165 medical oncologists in Michigan with Dmand AI profiles that report each measure.
Dr. Schuetze's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Schuetze?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Schuetze and other medical oncologists in Michigan.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Scott M. Schuetze treated 80 Medicare patients in 2024, average age 70
CMS counts 80 Medicare patients who saw Dr. Schuetze in 2024. The largest group is 65 to 74, with 35 patients. 71% of them have high blood pressure, and 61% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Schuetze's median patient age at 63, with 53% women.
Dr. Schuetze's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Schuetze's Medicare patients by sex, 2024
- Women3848%
- Men4253%
Chronic conditions among Dr. Schuetze's Medicare patients, 2024
- High blood pressure71%
- High cholesterol61%
- Anxiety38%
- Arthritis36%
- Ischemic heart disease36%
- Mood disorders34%
- Cancer33%
- Chronic kidney disease31%
Share of Medicare patients with each condition. A patient can have several.
Dr. Schuetze's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 63
Patient panel by sex, all payers
- Women53%
- Men47%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Scott M. Schuetze wrote 358 Medicare Part D claims in 2024
In 2024, Dr. Schuetze wrote 358 Medicare Part D claims for 74 patients. 86% of them were for generic drugs. CMS names the drug for 223 of them, across 7 drugs with 11 or more claims each, at $29,912 in total drug cost. In 2023, CMS named 216 claims across 6 drugs.
Dr. Schuetze's Part D claims by kind of drug, 2024
- Generic309 claims86%
- Brand-name49 claims14%
Dr. Schuetze's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Schuetze's Part D claims, 2024
- Opioids9%32 of 358 claims
- Antibiotics3%11 of 358 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 2162024: 2233%
Drugs named by CMS: 7 in 2024, 6 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Scott M. Schuetze offers telehealth to Medicare patients
Dr. Schuetze accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schuetze as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Scott M. Schuetze has 67 publications on record
Dmand AI links 67 papers to Dr. Schuetze, published from 2010 to 2025. 2015 was the busiest year, with 6. The most frequent topics are Sarcoma, Antineoplastic Combined Chemotherapy Protocols and Soft Tissue Neoplasms. Dr. Schuetze has published most often in J Natl Compr Canc Netw. Dr. Schuetze's most frequent co-authors are Rashmi Chugh, MD, Laurence H. Baker, DO and Kristen Nooshin Ganjoo, MD.
Dr. Schuetze's papers by year, 2015 to 2025
Topics Dr. Schuetze writes about most
- Sarcoma
- Antineoplastic Combined Chemotherapy Protocols
- Soft Tissue Neoplasms
- Chemotherapy, Adjuvant
- Antineoplastic Agents
- Biomarkers, Tumor
- Bone Neoplasms
- Doxorubicin
Dr. Schuetze's most frequent co-authors
- Rashmi Chugh, MD25 shared papers
- Laurence H. Baker, DO15 shared papers
- Kristen Nooshin Ganjoo, MD12 shared papers
Recent publications by Dr. Schuetze
J Clin Oncol
See who Dr. Schuetze researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Schuetze works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Scott M. Schuetze has worked on 11 clinical trials
Dmand AI links Dr. Schuetze to 11 clinical trials, 8 of them phase 2 studies. 4 are still active or recruiting. Conditions studied include Gastrointestinal Stromal Tumors, Histiocytoma and Liposarcoma. National Cancer Institute (NCI) sponsors the most, 4. Open Payments lists research payments to Dr. Schuetze that name 1 trial.
Clinical trials with Dr. Schuetze by phase
- NonePhase 1: no trials
- 8Phase 2: 8 trials
- 1Phase 2/3: 1 trial
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Schuetze's trials
- Gastrointestinal Stromal Tumors
- Histiocytoma
- Liposarcoma
- Liposarcoma, Myxoid
- Histiocytoma, Malignant Fibrous
Investigators on the most trials with Dr. Schuetze
- Mark Agulnik, MD4 shared trials
- Mihaela Druta, MD4 shared trials
- Kristen Nooshin Ganjoo, MD4 shared trials
Recent clinical trials with Dr. Schuetze
Phase 2 Study of Rogaratinib (BAY 1163877) in the Treatment of Patients With Sarcoma Harboring Alterations in Fibroblast Growth Factor Receptor (FGFR) 1-4 and SDH-Deficient Gastrointestinal Stromal Tumor (GIST) (opens in a new tab)
A Multicenter Phase II Trial of Paclitaxel With and Without Nivolumab in Taxane Naive, and Nivolumab and Cabozantinib in Taxane Pretreated Subjects With Angiosarcoma (opens in a new tab)
SARC038: A Phase 2 Study of Regorafenib in Combination With Nivolumab in Patients With Refractory or Recurrent Osteosarcoma (opens in a new tab)
Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Patients With Metastatic or Unresectable Sarcoma (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Scott M. Schuetze received $18,823 in industry payments from 2016 to 2025
CMS Open Payments shows 33 general payments to Dr. Schuetze from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 57% of the total. Boehringer Ingelheim USA, Inc. paid the most, $8,241. It also lists 2 research payments totaling $1,236 from 2016 to 2025, naming 1 clinical trial.
General payments to Dr. Schuetze by program year, 2016 to 2025
General payments to Dr. Schuetze by kind, 2016 to 2025
- Consulting fees$10,74057%
- Speaker and faculty fees$3,92121%
- Honoraria$1,7559%
- Travel and lodging$1,3447%
- Other$1,0636%
Companies that paid Dr. Schuetze the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Scott M. Schuetze graduated from Oregon Health Sciences University School of Medicine
Dr. Schuetze graduated from Oregon Health Sciences University School of Medicine in 1993.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Scott M. Schuetze's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Scott M. Schuetze
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Scott M. Schuetze's NPI number?
Dr. Scott M. Schuetze's NPI number is 1548346414. It was assigned on October 31, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Scott M. Schuetze?
Dr. Scott M. Schuetze is a medical oncologist in Ann Arbor, Michigan. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Scott M. Schuetze practice?
Dr. Schuetze practices at 1500 E Medical Center Dr, Ann Arbor, MI 48109. Dr. Schuetze's primary practice is University Hospital in Ann Arbor, Michigan.
What is Dr. Scott M. Schuetze's office phone number?
The practice phone on file for Dr. Schuetze is (734) 936-4000.
What is Dr. Scott M. Schuetze's medical license number?
Dr. Schuetze holds Michigan license 4301084113.
Which hospitals is Dr. Scott M. Schuetze affiliated with?
Dr. Schuetze is affiliated with University Hospital.
What medical group is Dr. Scott M. Schuetze part of?
Dr. Schuetze is linked to University of Michigan Health.
Does Dr. Scott M. Schuetze accept Medicare?
Yes. CMS data shows Dr. Schuetze billed Medicare for 209 services in 2024, and Dr. Schuetze accepts Medicare assignment.
Does Dr. Scott M. Schuetze offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Schuetze as offering telehealth services.
How many Medicare patients does Dr. Scott M. Schuetze see?
CMS counts 80 Medicare patients who saw Dr. Schuetze in 2024, with an average age of 70.
Show 7 more questionsShow fewer questions
What services does Dr. Scott M. Schuetze bill to Medicare?
In 2024, Dr. Schuetze's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99215) and medicare service (G2211).
Where did Dr. Scott M. Schuetze go to medical school?
Dr. Schuetze graduated from Oregon Health Sciences University School of Medicine in 1993.
What drugs does Dr. Scott M. Schuetze prescribe most?
In 2024 Medicare Part D data, Dr. Schuetze's most prescribed drugs by claims were Imatinib Mesylate, Dexamethasone and Ondansetron HCl.
Has Dr. Scott M. Schuetze received payments from drug or device companies?
CMS Open Payments shows $18,823 in general payments to Dr. Schuetze from 7 companies from 2016 to 2025. The largest total came from Boehringer Ingelheim USA, Inc.
How long has Dr. Scott M. Schuetze been practicing?
Dr. Schuetze graduated from medical school in 1993, 33 years ago.
Does Dr. Scott M. Schuetze do research?
Dmand AI links 67 publications to Dr. Schuetze, published from 2010 to 2025. Dr. Schuetze has worked on 11 clinical trials.
Who does Dr. Scott M. Schuetze publish with?
Dr. Schuetze's most frequent co-authors are Rashmi Chugh, MD (25 shared papers), Laurence H. Baker, DO (15 shared papers) and Kristen Nooshin Ganjoo, MD (12 shared papers).
Selling to medical oncology practices?
See medical oncologists in Michigan by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card